Pathology & Laboratory Medicine

Contemporary Results and Clinical Utility of Renal Mass Biopsies in the Setting of Ablative Therapy: A single center experience.

Ma LX, Craig KM, Mosquera JMiguel, Robinson BD, Scherr DS, Del Pizzo J, McClure TD, Khani F.  2020.  Contemporary Results and Clinical Utility of Renal Mass Biopsies in the Setting of Ablative Therapy: A single center experience.. Cancer Treat Res Commun. 25:100209.

Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM, a Prognostic Biomarker for Metastasis.

Entenberg D, Oktay MH, D'Alfonso T, Ginter PS, Robinson BD, Xue X, Rohan TE, Sparano JA, Jones JG, Condeelis JS.  2020.  Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM, a Prognostic Biomarker for Metastasis.. Cancers (Basel). 12(4)

Corrigendum to 'The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy' [European Urology Oncology 1 (2018) 263-267].

Patel N, Cricco-Lizza E, Kasabwala K, Xu C, Robinson BD, Khani F, Wang Y, Margolis D, Hu JC.  2020.  Corrigendum to 'The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy' [European Urology Oncology 1 (2018) 263-267].. Eur Urol Oncol. 3(3):394.

Nested Variant of Urothelial Carcinoma Is a Luminal Bladder Tumor With Distinct Coexpression of the Basal Marker Cytokeratin 5/6.

Johnson SM, Khararjian A, Legesse TB, Khani F, Robinson BD, Epstein JI, Wobker SE.  2021.  Nested Variant of Urothelial Carcinoma Is a Luminal Bladder Tumor With Distinct Coexpression of the Basal Marker Cytokeratin 5/6.. Am J Clin Pathol. 155(4):588-596.

Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.

Fine SW, Trpkov K, Amin MB, Algaba F, Aron M, Baydar DE, Beltran ALopez, Brimo F, Cheville JC, Colecchia M et al..  2021.  Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.. Urol Oncol. 39(5):295.e1-295.e8.

Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.

Zoughbi WAl, Kim D, Alperstein SAnn, Ohara K, Manohar J, Greco N, Khani F, Robinson BD, Rao RA, Elemento O et al..  2021.  Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.. Cancer Cytopathol.

Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center.

Pan PC, Pisapia DJ, Ramakrishna R, Schwartz TH, Pannullo SC, Knisely JPS, Chiang GC, Ivanidze J, Stieg PE, Liechty B et al..  2021.  Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center.. Neurooncol Adv. 3(1):vdab094.